Sinopep receives FDA approval letter

The company was audited by US FDA officer in April 2016. The US FDA officer thoroughly inspected the quality system of the company, especially the products which obtained a DMF number. Sinopep successfully passed the second regulatory audit of US FDA and received the approval letter in October, reflecting that the company is always strictly following the FDA standards of quality system, and is accepted by FDA

  • Peptides
  • Generic APIs
  • Custom Peptide Synthesis